Final results of a multicenter phase II study of the purine nucleoside phosphorylase (PNP) inhibitor forodesine in patients with advanced cutaneous t-cell lymphomas (CTCL) (Mycosis fungoides and Sézary syndrome)
R. Dummer, M. Duvic, J. Scarisbrick, E. A. Olsen, S. Rozati, N. Eggmann, S. M. Goldinger, K. Hutchinson, L. Geskin, T. M. Illidge, E. Giuliano, J. Elder, Y. H. Kim
Research output: Contribution to journal › Article › peer-review
Dive into the research topics of 'Final results of a multicenter phase II study of the purine nucleoside phosphorylase (PNP) inhibitor forodesine in patients with advanced cutaneous t-cell lymphomas (CTCL) (Mycosis fungoides and Sézary syndrome)'. Together they form a unique fingerprint.